Standardization of marker assays - pyridinoline/deoxypyridinoline

References

• Fujimoto D, Moriguchi T, Ishida T, Hayashi H. The structure of pyridinoline, a collagen crosslink. Biochem Biophys Res Commun 1978; 84: 52–7
   PubMed Web of Science ®Google Scholar
• Ogawa T, Ono T, Tsuda M, Kawanishi Y. A novel fluor in insoluble collagen: a crosslinking moiety in collagen molecule. Biochem Biophys Res Comm 1982; 107: 1252–7
   PubMed Web of Science ®Google Scholar
• Eyre D R, Paz M A, Gallop P M. Cross-linking in collagen and elastin. Ann Rev Biochem 1984; 53: 717–48
   PubMed Web of Science ®Google Scholar
• Eyre D R, Koob T J, Van Ness K P. Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Anal Biochem 1984; 137: 380–8
   PubMed Web of Science ®Google Scholar
• Eyre D R, Dickson I R, Van Ness K. Collagen cross-linking in human bone and articular cartilage. Biochem J 1988; 252: 495–500
   PubMed Web of Science ®Google Scholar
• Robins S P, Duncan A, Riggs B L. Direct measurement of free hydroxy-pyridinium crosslinks of collagen in urine as markers of bone resorption in osteoporosis. Osteoporosis 1990, C Christiansen, K Overgaard. Osteopress, Copenhagen 1990; 465–8
   Google Scholar
• Eyre D R. The specificity of collagen cross-links as markers of bone and connective tissue degradation. Acta Orthop Scand 1995; 66: 166–170, (Suppl. 266)
   PubMed Web of Science ®Google Scholar
• Pearce D, Fisher E, Randall A, Will R K, Kent G N, Garcia-Webb P. Urinary levels of pyridinoline and deoxypyridinoline may be influenced by turnover of non-osseous tissues in patients with joint disease. Brit J Rheumatol 1995; 34: 1186–7
   PubMedGoogle Scholar
• Robins S P. Crosslinking of collagen. Isolation, structural characterisation and glycosylation of pyridinoline. Biochem J 1983; 215: 167–73
   PubMed Web of Science ®Google Scholar
• Hanson D A, Weiss M-AE, Bollen A-M, Maslan S L, Singer F R, Eyre D A. A specific radioimmunoassay for monitoring human bone resoprtion. Quantitation of type I collagen cross-linked, N-telopeptides in urine. J Bone Miner Res 1992; 7: 1251–8
   PubMed Web of Science ®Google Scholar
• Colwell A, Russell R GG, Eastell R. Factors affecting the assay of urinary 3-hydroxypyridinium crosslinks of collagen as markers of bone resorption. Eur J Clin Invest 1993; 23: 341–9
   PubMed Web of Science ®Google Scholar
• Robins S P, Black D, Paterson C R, Reid D M, Duncan A, Seibel M J. Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases. Eur J Clin Invest 1991; 21: 310–5
   PubMed Web of Science ®Google Scholar
• Seibel M J, Cosman F, Shen V, Gordon S, Dempster D W, Ratcliffe A, Lindsay R. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis. J Bone Miner Res 1993; 8: 881–9
   PubMed Web of Science ®Google Scholar
• Seibel M J, Duncan A, Robins S P. Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases. J Rheumatol 1989; 16: 964–70
   PubMed Web of Science ®Google Scholar
• Fujimoto D, Suzuki M, Uchiyama A, Miyamoto S, Inoue T. Analysis of pyridinoline, a cross-linking compound of collagen fibers, in human urine. J Biochem 1983; 94: 1133–6
   PubMedGoogle Scholar
• Black D, Duncan A, Robins S P. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal Biochem 1988; 169: 197–203
   PubMed Web of Science ®Google Scholar
• Pratt D A, Daniloff Y, Duncan A, Robins S P. Automated analysis of the pyridinium crosslinks of collagen in tissue and urine using solid-phase extraction and reversed-phase high-performance liquid chromatography. Anal Biochem 1992; 207: 168–75
   PubMed Web of Science ®Google Scholar
• Randall A G, Kent G N, Garcia-Webb P, Bhagat C I, Pearce D J, Gutteridge D H, Prince R L, Stewart G, Stuckey B, Will R K, Retallack R W, Price R I, Ward L. Comparison of biochemical markers of bone turnover in Paget's disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links. J Bone Miner Res 1996; 11: 1176–84
   PubMedGoogle Scholar
• Robins S P, Woitge H, Hesley R, Ju J, Seyedin S, Siebel M J. A direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res 1994; 9: 1643–9
   PubMed Web of Science ®Google Scholar
• Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 1993; 39: 635–40
   PubMed Web of Science ®Google Scholar
• Bonde M, Qvist P, Fledelius C, Riis B J, Christiansen C. Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem 1994; 40: 2022–5
   PubMed Web of Science ®Google Scholar
• Robins S. Collagen crosslinks in metabolic bone disease. Acta Orthop Scand 1995; 66: 171–5, (Suppl. 266)
   Web of Science ®Google Scholar
• Kamel S, Brazier M, Neri V, Picard C, Damson L, Desmet G, Sebert J L. Multiple molecular forms of pyridinolines cross-links excreted in human urine evaluated by chromatographic and immunoassay methods. J Bone Miner Res 1995; 10: 1385–92
   PubMed Web of Science ®Google Scholar
• Garnero P, Gineyts E, Arbault P, Christiansen C, Delmas P D. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. J Bone Miner Res 1995; 10: 641–9
   PubMed Web of Science ®Google Scholar
• Seyedin S, Kung V T, Danilov Y N, Hesley R P, Gomez B, Nielsen L A, Rosen H N, Zuk R F. Immunoassay for urinary pyridinoline: the new marker of bone resorption. J Bone Miner Res 1993; 8: 635–41
   PubMed Web of Science ®Google Scholar
• Bonde M, Fledelius C, Qvist P, Christiansen C. Coated-tube radioimmunoassay for C-telopeptides of type I collagen to assess bone resorption. Clin Chem 1996; 42: 1639–44
   PubMedGoogle Scholar
• Blumsohn A, Colwell A, Naylor K, Eastell R. Effect of light and γ-irradiation on pyridinolines and telopeptides of type I collagen in urine. Clin Chem 1995; 41: 1195–7
   PubMed Web of Science ®Google Scholar
• Robins S, Duncan A, Wilson N, Evans B J. Standardization of pyridinium crosslinks, pyridinoline and deoxypyridinoline, for use as biochemical markers of collagen degradation. Clin Chem 1996; 42: 1621–26
   PubMed Web of Science ®Google Scholar
• Siebel M J, Robins S P, Bilezikian J P. Urinary pyridinium crosslinks of collagen: specific markers of bone resorption in metabolic bone disease. Trends Endocrinol Metab 1992; 3: 263–70
   PubMed Web of Science ®Google Scholar